GetTopicDetailResponse(id=77a312e022e3, topicName=椎體終板骨髓水腫, introduction=, content=TNF抑制劑 椎體終板骨髓水腫, image=null, comments=0, allHits=156, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon May 19 10:41:30 CST 2025, time=2025-05-19, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=504632, tagList=[TagDto(tagId=504632, tagName=椎體終板骨髓水腫)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2265676, encodeId=2dd522656e6f4, content=<a href='/topic/show?id=e1b91e60105' target=_blank style='color:#2F92EE;'>#TNF抑制劑#</a> <a href='/topic/show?id=77a312e022e3' target=_blank style='color:#2F92EE;'>#椎體終板骨髓水腫#</a>, objectTitle=Arthritis Rheumatol：標準劑量infliximab治療MCs 1型慢性腰痛5個月未顯著改善疼痛相關殘疾或生活質(zhì)量, objectType=article, longId=878123, objectId=02cf8e8123ea, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250519/1747622424582_92910.png, objectUrl=/article/show_article.do?id=02cf8e8123ea, replyNumber=0, likeNumber=29, createdTime=2025-05-19, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=02cf8e8123ea, moduleTitle=Arthritis Rheumatol：標準劑量infliximab治療MCs 1型慢性腰痛5個月未顯著改善疼痛相關殘疾或生活質(zhì)量, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=02cf8e8123ea)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-05-19發(fā)表于上海
